TGFB1 and left ventricular hypertrophy: In the same hypertensive patient group, treatment with losartan (a clinically approved angiotensin II receptor antagonist with TGF-β inhibitory activity) decreased TGF-β1 levels in some of the patients, which correlated with a reduction of microalbuminuria and left ventricular hypertrophy [88].